Exploration of the association between SF3B4 and HMGB1 expression and the clinicopathological features and prognosis of gastric cancer

doi:10.4251/wjgo.v17.i8.109120

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 17, Issue 8

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (0)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-3) series, Tables (1-7) series.

Item

Count

PDF

HTML

Figures (1-3)

Tables (1-7)

Sum=0

Aug 15, 2025 (publication date) through Aug 14, 2025

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Oncology

ISSN

1948-5204

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Cohort Study

World J Gastrointest Oncol. Aug 15, 2025; 17(8): 109120
Published online Aug 15, 2025. doi: 10.4251/wjgo.v17.i8.109120

Exploration of the association between SF3B4 and HMGB1 expression and the clinicopathological features and prognosis of gastric cancer

Min-Yue Shou, Yu-Qing Liu, Yong-Qian Shu

Min-Yue Shou, Yu-Qing Liu, Yong-Qian Shu, Department of Oncology, The First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, Jiangsu Province, China

Author contributions: Shou MY and Liu YQ contributed to the design and implementation of the research; Shu YQ contributed to the analysis of the results and the writing of the manuscript. All authors approved the final version to publish.

Institutional review board statement: This study was approved by the Ethics Committee of The First Affiliated Hospital of Nanjing Medical University, No. 2024-SRFA-940.

Informed consent statement: Informed consent was obtained from all study participants.

Conflict-of-interest statement: All the authors report no relevant conflicts of interest for this article.

STROBE statement: The authors have read the STROBE Statement-checklist of items, and the manuscript was prepared and revised according to the STROBE Statement-checklist of items.

Data sharing statement: No additional data are available.

Open Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/

Corresponding author: Yong-Qian Shu, Chief Physician, Department of Oncology, The First Affiliated Hospital of Nanjing Medical University, No. 300 Guangzhou Road, Nanjing 210029, Jiangsu Province, China. shoutg25@163.com

Received: May 23, 2025
Revised: June 15, 2025
Accepted: July 14, 2025
Published online: August 15, 2025
Processing time: 82 Days and 15.6 Hours

Core Tip

Core Tip: The expression levels of splicing factor 3b subunit 4 and high mobility group box 1 in gastric biopsy tissues of gastric cancer patients are significantly elevated, and their expression is closely related to disease severity, prognosis, and survival time. They can serve as biomarkers for evaluating disease status and prognosis in gastric cancer, and their combined detection has a higher predictive value for poor prognosis than individual diagnosis.